Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Betta Pins Hopes On New Overseas JV Amid Challenges

Executive Summary

Betta Pharmaceuticals hopes strategic initiatives overseas will facilitate its diversification away from a single dominant oncology product. The Chinese firm is facing increasing competition from domestic generics, with revenues and profits under pressure.

Advertisement

Related Content

Deal Watch: Inventiva Expands Collaborations With Boehringer, AbbVie
Asia Executives To Watch: Betta CEO Quits To Nurture Drug Startups
China Investment Roundup: Strategic Overseas Moves Target Product Acquisitions
Betta IPO: New Hope For Made In China Innovation?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel